The effect of a Persian medicine product on patients with severe persistent asthma
Phase 3
Recruiting
- Conditions
- Asthma.Severe persistent asthma
- Registration Number
- IRCT20170112031893N5
- Lead Sponsor
- Ghoum University of Medical Sciences
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Recruiting
- Sex
- All
- Target Recruitment
- 80
Inclusion Criteria
Patients with severe persistent asthma over a year
Age group 12-80
Exclusion Criteria
Kidney,liver,and heart failure based on the tests, history and physical exam
High blood pressure more than 180 mm Hg
Fever
Pergnancy and lactation;
Study & Design
- Study Type
- interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Forced Expiratory Volume in First Second. Timepoint: Before and after the intervention (end of month 3). Method of measurement: Spirometry testing.
- Secondary Outcome Measures
Name Time Method Wheezing intensity determination. Timepoint: At the first of the study(before intervention) and 3 months after intervention. Method of measurement: History and physical exam with stethoscope.